CHS Dream of a Cure Research Grants
The CHS Dream of a Cure Research Grants fund basic research into the causes and treatment of inherited bleeding disorders, supported by the Canadian Hemophilia Society.
Funder: Canadian Hemophilia Society
Due Dates: November 28, 2025 | November 28, 2026
Funding Amounts: Up to $75,000/year, maximum $150,000/project over 2–3 years
Summary: Funds basic scientific research advancing understanding and treatment of inherited bleeding disorders in Canada.
Description
The CHS Dream of a Cure Research Grants support basic scientific research in fields relevant to inherited bleeding disorders, including hemophilia A and B, von Willebrand disease, rare factor deficiencies, and platelet function disorders. The program aims to advance scientific understanding, develop improved therapies and management strategies, and ultimately find a cure. Grants are awarded through a competitive, peer-reviewed process and are intended for research that will have a direct impact on the health and quality of life of individuals living with congenital and acquired bleeding disorders in Canada.
